- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03757780
Low Birth Weight Fetuses With Caffeine Use
January 8, 2019 updated by: Aljazeera Hospital
Association of Low Birth Weight Fetuses With Caffeine Use
Globally, it has been estimated that 15.5% of all infantsare born low birth weight, defined as birthweight less than 2,500 g .
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
Low birth weight is not only associated with neonatal mortality and morbidity.
but also with a higher risk of chronic diseases such as type 2 diabetes and cardiovascular diseases in adult life
Study Type
Observational
Enrollment (Anticipated)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Giza, Egypt
- Recruiting
- Algazeerah and Kasralainy hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
Age group: 18-40
•Pregnant females attending regular post-natal care visits
Description
Inclusion Criteria:
- Age group: 18-40
- Pregnant females attending regular post-natal care visits
Exclusion Criteria:
• Female patients with other acute or chronic illness
- Cardiovascular disease
- Neoplasms
- Current diabetes mellitus, pregnancy induced diabetes
- Renal impairment (serum creatinine 120 mol/liter), and hypertension (blood pressure 140/85 mm Hg).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Pregnant ladies who are caffeine using
ladies who uses caffeine during pregnancy
|
A questionaire will be made to pregnant ladies who take caffeine during pregnancy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The number of pregnant ladies who will have low birth weight babies
Time Frame: within 2 months
|
Mothers who will give birth to low birth weight infants
|
within 2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Chair: Mahmoud Alalfy, Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 30, 2018
Primary Completion (Anticipated)
February 1, 2019
Study Completion (Anticipated)
February 15, 2019
Study Registration Dates
First Submitted
November 27, 2018
First Submitted That Met QC Criteria
November 27, 2018
First Posted (Actual)
November 29, 2018
Study Record Updates
Last Update Posted (Actual)
January 9, 2019
Last Update Submitted That Met QC Criteria
January 8, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- low birth weight
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Low; Birthweight, Extremely (999 Grams or Less)
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeRecruitingPreterm Infant | Low; Birthweight, Extremely (999 Grams or Less) | Infant, NewbornUnited Kingdom
-
Outi AikioCompletedPrematurity; Extreme | Low Birthweight, Extremely (999 Grams or Less)Finland
-
PediatrixBanner University Medical CenterCompletedLow; Birthweight, Extremely (999 Grams or Less) | PDAUnited States
-
Harvard School of Public Health (HSPH)Eunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruitingPreterm Birth | Low; Birthweight, Extremely (999 Grams or Less)United States
-
Philips HealthcareMemorial Hospital of South BendWithdrawnStress | Preterm Birth | Growth Acceleration | Chronic Lung Disease | Satisfaction | Adverse Event | Low; Birthweight, Extremely (999 Grams or Less) | Neonatal InfectionUnited States
-
Philips HealthcareChildren's Hospital and Medical Center, Omaha, NebraskaWithdrawnStress | Preterm Birth | Growth Acceleration | Chronic Lung Disease | Satisfaction | Adverse Event | Low; Birthweight, Extremely (999 Grams or Less) | Neonatal InfectionUnited States
-
Dr Cipto Mangunkusumo General HospitalFakultas Kedokteran Universitas Indonesia; Dinas Kesehatan DKI JakartaRecruitingPregnancy Complications | Preterm Birth | Preeclampsia | Asphyxia Neonatorum | Low; Birthweight, Extremely (999 Grams or Less) | Maternal Death | IUGR | Neonatal Death | Pregnancy Hemorrhage | Intrauterine InfectionIndonesia
-
Abant Izzet Baysal UniversityHacettepe UniversityUnknownCerebral Palsy | Down Syndrome | Premature Infants | Spina Bifida | Metabolic Disorders | Low; Birthweight, Extremely (999 Grams or Less)
-
PHCC LPCompletedPreterm Birth | Low Birth Weight <2500 Grams | Verylow Birthweight <1500 GramsUnited States
-
Singapore General HospitalCompletedVery Low Birth Weight Infant | Neonatal Hypoglycemia | Extremely Low Birth Weight | Extreme Prematurity,Extremely Low BirthweightSingapore
Clinical Trials on Questionaire
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Memorial Sloan Kettering Cancer CenterFox Chase Cancer Center; University of ChicagoRecruitingBladder Cancer | Urothelial Cancer | Ureter Cancer | Renal Pelvis CancerUnited States
-
Sygehus LillebaeltKolding SygehusCompleted
-
University Hospital Inselspital, BerneCompletedSexual Orientation | Family CharacteristicsSwitzerland
-
Fayoum UniversityCompleted
-
The Cleveland ClinicUnknownSleep Apnea | Adverse EventUnited States
-
Hospices Civils de LyonCompletedAnoxic-Ischemic EncephalopathyFrance
-
Hillel Yaffe Medical CenterCompletedConditions Influencing Health StatusIsrael
-
Eurofertil IVF Health CenterCompletedStress | PregnancyTurkey
-
Zurich University of Applied SciencesCompleted